BSPK — Bespoke Extracts, Inc.
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1409197 ·
Last close
$0.18
Market Cap
$1.98M
52W High
$0.26
52W Low
$0.17
ADV30
1,762
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2025 | 467,945 | 234,175 | -53,891 | -78,088 | 295,573 | 16,743 | 2,891,081 |
| Jun 2025 | 390,553 | 197,499 | -161,958 | -205,106 | 267,038 | 1,363 | 2,806,344 |
| Mar 2025 | 263,159 | 110,779 | -245,338 | -260,521 | 248,125 | 30,365 | 2,582,325 |
| Dec 2024 | 301,390 | 129,242 | -179,114 | -186,849 | 359,088 | 60,305 | 2,451,026 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-259,702
Investing CF
—
Financing CF
$255,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.06
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-26,947,831
Inventory
$63,662
Receivables
$103,532
ST Investments
—
EBIT TTM
$-623,075
Pretax Income TTM
$-730,564
Interest Exp TTM
$107,489
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,423,047
EBITDA
$-630,393
Free Cash Flow
$-433,311
Enterprise Value
$3,462,094
Total Cash
$16,743
Total Debt
$1,498,212
Shares Out
11,253,552
Trailing EPS
$-0.07
Book Value
$-0.23
ROE
—
ROA
-126.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 3y)
Revenues vs Net Income (last 3y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2024 | 1,117,452 | -994,628 | -1,037,475 | 359,088 | 2,451,026 | — | -289,802 |
| Dec 2023 | 785,453 | -1,471,978 | -1,482,843 | 354,360 | 2,078,917 | — | -415,198 |
| Dec 2022 | 3,407 | -4,102,355 | -4,116,227 | 409,591 | 1,081,687 | — | -798,067 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AXIM | AXIM BIOTECHNOLOGIES, INC. | $1.80M | $0.01 | — |
| HEPA | Hepion Pharmaceuticals, Inc. | $2.18M | $0.08 | — |
| UPC | Universe Pharmaceuticals INC | $1.65M | $2.61 | — |
| CLSDQ | Clearside Biomedical, Inc. | $1.65M | $0.31 | — |
| PCYN | PROCYON CORP | $1.64M | $0.20 | — |
News headlines (Yahoo Finance, 1h cache)
Bespoke Extracts, Inc. Reports Third Quarter 2025 Results – The Joint Company Scales Colorado Production and Margin Leadership
2025-11-12 13:00 · Yahoo
Bespoke Extracts, Inc. Announces Financial Results for the Second Quarter ended June 30, 2025
2025-08-27 20:10 · Yahoo
Bespoke Extracts, Inc. Announces Financial Results and Strategic Rebranding for the First Quarter Ended March 31, 2025
2025-07-01 15:16 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.